ROR
RAR-related orphan receptor
Retinoic acid receptor-related orphan receptors (RORs) are a subfamily of the thyroid hormone receptor, which is a subfamily of the nuclear receptors and belonging to the orphan nuclear receptor family. The ROR subfamily contains three members: RORα (NR1F1), RORβ (NR1F2), and RORγ (NR1F3) and function as ligand-dependent transcription factors.
RORs are reported to activate transcription through ligand-dependent interactions with co-regulators and are involved in the development of secondary lymphoid tissues, autoimmune diseases, inflammatory diseases, the circadian rhythm, and metabolism homeostasis.
RORα and RORγ are important regulators of the immune system. The development and differentiation of Th17 cells are dependent on these factors. RORγ is expressed in lymphoid tissue inducer cells, innate lymphoid cells, invariant natural killer T cells, and γδ T cells, which contribute to inflammation and autoimmune disease.
ROR Isoform Specific Products
All Product Categories
-
ROR Inhibitors
(59)
View all products
-
ROR Agonists
(29)
View all products
-
ROR Antagonists
(37)
View all products
-
ROR Activators
(2)
View all products
-
ROR Modulators
(8)
View all products
-
ROR Inducer
(1)
View all products
-
ROR Degraders
(2)
View all products
-
ROR Control
(1)
View all products
-
ROR Ligands
(3)
View all products
-
ROR Related Products (148)
Related Products (148)
-
Antibodies (5)
-
ROR Isoform Comparison
-
SR-1903
0 ImagesCat. No.: HY-138007CAS No.: 1414248-06-8
-
RORγ/DHODH-IN-1
0 ImagesCat. No.: HY-169220SCAS No.: 3000567-76-7RORγ/DHODH-IN-1 (compound 1404), a deuterium labeled compound, is a dual RORγ and DHODH inhibitor with IC50 values of 9.7 nM and 100 nM, repaectively. RORγ/DHODH-IN-1 blocks the replication of SARS-CoV-2, HCMV, and non-enveloped DNA virus (HAdV5).
-
TMP778 (Standard)
0 ImagesCat. No.: HY-102075ARCAS No.: 1422053-04-0TMP778 (Standard) is the analytical standard of TMP778 (HY-102075A). This product is intended for research and analytical applications. TMP778 is a potent and selevtive RORγt inverse agonist, with an IC50 of 7 nM in FRET assay.
-
T0901317 (Standard)
0 ImagesT0901317 (Standard) is the analytical standard of T0901317. This product is intended for research and analytical applications. T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα. T0901317 activates FXR with an EC50 of 5 μM. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice.
-
Cintirorgon sodium
0 ImagesCat. No.: HY-104037ACAS No.: 2055538-47-9Synonyms: LYC-55716 sodiumCintirorgon sodium is a first-in-class, selective and orally bioavailable RORγ agonist. Cintirorgon sodium (LYC-55716) modulates gene expression of RORγ expressing T lymphocyte immune cells, resulting in enhanced effector function, as well as decreased immunosuppression, resulting in decreased tumor growth, and improved survival.
-
RORγ/DHODH-IN-2
0 ImagesCat. No.: HY-169222SCAS No.: 3000567-45-0RORγ/DHODH-IN-2 (Compound 1311) is an orally active dual inhibitor of RORγ/DHODH with IC50 values of 11.9 nM and 90 nM, respectively. RORγ/DHODH-IN-2 exhibits antiviral activity by inhibiting the activity of SARS-CoV-2, HCMV, HAdV5, and MPXV, with IC50 values of 27 nM, 20 nM, 9.1 nM, and 1.8 nM, respectively.
-
Neoruscogenin (Standard)
0 ImagesCat. No.: HY-N2253RCAS No.: 17676-33-4Neoruscogenin (Standard) is the analytical standard of Neoruscogenin. This product is intended for research and analytical applications. Neoruscogenin, a member of the steroidal sapogenin family, is a high-affinity agonist of the nuclear receptor RORα (NR1F1) (EC50 = 0.11 μM).
-
Vimirogant
0 ImagesCat. No.: HY-103637CAS No.: 1802706-04-2Synonyms: VTP-43742Vimirogant (VTP-43742) is a potent, selective, and orally active RORγt inhibitor (Ki=3.5 nM; IC50=17 nM). Vimirogant exhibits >1000-fold selectivity versus the RORα and RORβ isotypes. Vimirogant inhibits Th17 differentiation and IL-17A secretion from mouse splenocytes (IC50=57 nM) without affecting Th1, Th2, or Treg cell differentiation. Vimirogant has the potential for autoimmune disorders research.
